Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 8, 2024Alimentary Pharmacology & Therapeutics

Review article: Contemporary management of gastrointestinal, pancreatic and hepatic toxicities of immune checkpoint inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

MTMatthew J. TownsendMassachusetts General HospitalIBIsaac J BenqueUniversity of California, San FranciscoMLMichael LiPeter MacCallum Cancer Centre

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Townsend et al. (2024) studied this question.

synapsesocial.com/papers/68e6ffe7b6db6435876797e7https://doi.org/10.1111/apt.17980
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors2018 · 590 citations
  2. 2Immune Checkpoint Inhibitor–Mediated Diarrhea and Colitis: A Clinical Review2020 · 73 citations
  3. 3Upper gastrointestinal symptoms and associated endoscopic and histological features in patients receiving immune checkpoint inhibitors2019 · 87 citations
  4. 4Immune checkpoint inhibitor-associated celiac disease2020 · 70 citations